ClinicalTrials.gov record
Active, not recruiting Not applicable Interventional

Patient-Centered Outcomes in the Surgical Treatment of Uterovaginal Prolapse

ClinicalTrials.gov ID: NCT05063331

Public ClinicalTrials.gov record NCT05063331. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 18, 2026, 1:02 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Patient-Centered Outcomes of Sacrocolpopexy Versus Uterosacral Ligament Suspension for the Treatment of Uterovaginal Prolapse

Study identification

NCT ID
NCT05063331
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Not applicable
Lead sponsor
University Hospitals Cleveland Medical Center
Other
Enrollment
300 participants

Conditions and interventions

Interventions

  • Minimally invasive supracervical hysterectomy and sacrocolpopexy (MI-SCH+SCP) Procedure
  • Vaginal hysterectomy with uterosacral ligament suspension (TVH+USLS) Procedure

Procedure

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 14, 2021
Primary completion
May 30, 2029
Completion
May 30, 2029
Last update posted
May 14, 2026

2021 – 2029

United States locations

U.S. sites
7
U.S. states
5
U.S. cities
5
Facility City State ZIP Site status
Mayo Clinic Jacksonville Florida 32224
Northwestern Medicine Chicago Illinois 60611
Duke University Durham North Carolina 27707
University Hospitals Cleveland Medical Center Cleveland Ohio 44106
MetroHealth Medical Center Cleveland Ohio 44109
Cleveland Clinic Cleveland Ohio 44195
University of Pittsburgh, UPMC Magee-Womens Hospital Pittsburgh Pennsylvania 15213

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05063331, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 14, 2026 · Synced May 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05063331 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →